Morgan Stanley Macrogenics Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Macrogenics Inc stock. As of the latest transaction made, Morgan Stanley holds 319,869 shares of MGNX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

319,869

Previous 472,237 32.27%

Holding current value

$1.04 Million

Previous $2.01 Million 47.58%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.0 - $5.55 $457,104 - $845,642	-152,368 Reduced 32.27%	319,869 $1.05 Million
Q2 2024 Oct 17, 2024	BUY	$3.31 - $18.51 $861,556 - $4.82 Million	260,289 Added 122.81%	472,237 $2.01 Million
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $861,556 - $4.82 Million	260,289 Added 122.81%	472,237 $2.01 Million
Q1 2024 Oct 17, 2024	SELL	$9.77 - $21.47 $2.54 Million - $5.59 Million	-260,289 Reduced 55.12%	211,948 $3.12 Million
Q1 2024 Aug 16, 2024	SELL	$9.77 - $21.47 $1.36 Million - $2.99 Million	-139,227 Reduced 39.65%	211,948 $3.12 Million
Q1 2024 May 15, 2024	SELL	$9.77 - $21.47 $1.36 Million - $2.99 Million	-139,227 Reduced 39.65%	211,948 $3.12 Million
Q4 2023 Aug 16, 2024	SELL	$4.48 - $10.11 $542,357 - $1.22 Million	-121,062 Reduced 25.64%	351,175 $3.38 Million
Q4 2023 Feb 13, 2024	SELL	$4.48 - $10.11 $9,416 - $21,251	-2,102 Reduced 0.6%	351,175 $3.38 Million
Q3 2023 Nov 15, 2023	SELL	$4.48 - $6.19 $405,341 - $560,058	-90,478 Reduced 20.39%	353,277 $1.65 Million
Q2 2023 Aug 14, 2023	SELL	$4.62 - $7.54 $922,609 - $1.51 Million	-199,699 Reduced 31.04%	443,755 $2.37 Million
Q1 2023 May 15, 2023	SELL	$4.82 - $7.24 $18,161 - $27,280	-3,768 Reduced 0.58%	643,454 $4.61 Million
Q4 2022 Feb 14, 2023	SELL	$3.34 - $6.98 $441,300 - $922,239	-132,126 Reduced 16.95%	647,222 $4.34 Million
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $306,715 - $531,912	101,899 Added 15.04%	779,348 $2.7 Million
Q2 2022 Oct 27, 2022	BUY	$2.25 - $9.99 $144,753 - $642,706	64,335 Added 10.49%	677,449 $2 Million
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $144,753 - $642,706	64,335 Added 10.49%	677,449 $2 Million
Q1 2022 Oct 27, 2022	SELL	$8.12 - $16.9 $522,400 - $1.09 Million	-64,335 Reduced 9.5%	613,114 $5.4 Million
Q1 2022 May 13, 2022	BUY	$8.12 - $16.9 $2.98 Million - $6.2 Million	367,149 Added 149.27%	613,114 $5.4 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $3.35 Million - $4.61 Million	210,621 Added 595.92%	245,965 $3.95 Million
Q3 2021 Nov 15, 2021	BUY	$19.74 - $28.7 $697,690 - $1.01 Million	35,344 New	35,344 $740,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account